Jump to content

Pyr-T

From Wikipedia, the free encyclopedia
Pyr-T
Names
Preferred IUPAC name
3-[2-(Pyrrolidin-1-yl)ethyl]-1H-indole
Other names
N,N-Tetramethylenetryptamine
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C14H18N2/c1-2-6-14-13(5-1)12(11-15-14)7-10-16-8-3-4-9-16/h1-2,5-6,11,15H,3-4,7-10H2checkY
    Key: CVTZCBLFHNGYDQ-UHFFFAOYSA-NcheckY
  • InChI=1/C14H18N2/c1-2-6-14-13(5-1)12(11-15-14)7-10-16-8-3-4-9-16/h1-2,5-6,11,15H,3-4,7-10H2
    Key: CVTZCBLFHNGYDQ-UHFFFAOYAE
  • c2c(c1ccccc1[nH]2)CCN3CCCC3
Properties
C14H18N2
Molar mass 214.312g·mol−1
Melting point 193 to 194 °C (379 to 381 °F; 466 to 467 K) (HCl salt.)
Boiling point 170 to 180 °C (338 to 356 °F; 443 to 453 K) (Freebase at 0.05mm/Hg.)
logP 2.74410
Vapor pressure 1.02x10−5mmHg
Except where otherwise noted, data are given for materials in theirstandard state(at 25 °C [77 °F], 100 kPa).

Pyr-T(N,N-tetramethylenetryptamine) is a lesser-known, possiblepsychedelic drug.Pyr-T was first characterized by S. Mitzal.[1]Toxicity testing was later performed by Hunt and Brimblecombe, and although a lethal dosage was found in rats, a value is not given.[2]In the bookTiHKAL(Tryptamines I Have Known and Loved), neither the dosage nor the duration are reported.[3][4]

Pyr-T produces few to no effects in humans, but some behavioral changes were observed in animal tests.[2]Very little data exists about the pharmacological properties, metabolism, and toxicity of pyr-T.

See also

[edit]

References

[edit]
  1. ^Mitzal, S. (1962). "N/A".Dissertationes Pharm.14:305.
  2. ^abHunt, R. R.; Brimblecombe, R. W. (July 1967). "Synthesis and Biological Activity of Some Ring-Substituted Tryptamines".Journal of Medicinal Chemistry.10(4): 646–648.doi:10.1021/jm00316a027.PMID4962512.
  3. ^Shulgin, Alexander; Shulgin, Ann (1997).TiHKAL, The Continuation(1st ed.). Berkeley, CA, USA: Transform Press. pp. 577–578.ISBN0-9630096-9-9.Retrieved7 April2018.
  4. ^Krasowski MD, Ekins S. Using cheminformatics to predict cross reactivity of “designer drugs” to their currently available immunoassays.J Cheminform6, 22 (2014).doi:10.1186/1758-2946-6-22